| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/28/2007 | EP1766069A2 Devices and methods for removing target agents from a sample |
| 03/28/2007 | EP1766068A2 Egfr mutations |
| 03/28/2007 | EP1766067A1 Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
| 03/28/2007 | EP1766066A2 Screening for compounds that affect the pathophysiologic mechanisms of neurological disorders |
| 03/28/2007 | EP1766065A2 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA |
| 03/28/2007 | EP1766064A1 Methods and devices for sequencing nucleic acids |
| 03/28/2007 | EP1766063A2 Methods and kits to detect hereditary angioedema type iii |
| 03/28/2007 | EP1766062A2 Method of detecting cystic fibrosis associated mutations |
| 03/28/2007 | EP1766061A2 Single label comparative hybridization |
| 03/28/2007 | EP1766060A1 Methods of diagnosing and prognosticating solid tumors and melanoma |
| 03/28/2007 | EP1766059A2 Influenza hemagglutinin and neuraminidase variants |
| 03/28/2007 | EP1766058A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 03/28/2007 | EP1766057A2 Methods and devices related to a regulated flow electroporation chamber |
| 03/28/2007 | EP1766056A1 Oligonucleotides for cancer diagnosis |
| 03/28/2007 | EP1766055A1 Method for stabilizing assay reagents, reagent container with stabilized assay reagents and use thereof |
| 03/28/2007 | EP1766054A1 Compositions and methods |
| 03/28/2007 | EP1766053A2 Rna-containing microvesicles and methods therefor |
| 03/28/2007 | EP1766052A1 Chimeric gapped oligomeric compositions |
| 03/28/2007 | EP1766051A1 Methods for identifying risk of breast cancer and treatments thereof |
| 03/28/2007 | EP1766050A1 Assay system using labeled oligonucleotides |
| 03/28/2007 | EP1766049A1 A method for detecting analytes in a sample |
| 03/28/2007 | EP1766048A2 Method and device for monitoring aspirin response |
| 03/28/2007 | EP1766047A2 Hif prolyl hydroxylase activity assay |
| 03/28/2007 | EP1766046A1 High ph test system for the determination of the presence of an antibiotic in a fluid |
| 03/28/2007 | EP1766045A2 Hematology reference control containing an immature granulocyte component |
| 03/28/2007 | EP1766044A2 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |
| 03/28/2007 | EP1766043A2 Computer systems and methods for constructing biological classifiers and uses thereof |
| 03/28/2007 | EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 03/28/2007 | EP1766041A2 Methods for identifying risk of breast cancer and treatment thereof |
| 03/28/2007 | EP1766025A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 03/28/2007 | EP1766022A1 Detecting disease association with aberrant glycogen synthase kinase 3 beta expression |
| 03/28/2007 | EP1766021A1 Polynucleotides for the detection of escherichia coli 157:h7 and escherichia coli 0157:nm verotoxin producers |
| 03/28/2007 | EP1766020A1 Polynucleotides for the detection of staphylococcus aureus |
| 03/28/2007 | EP1766014A1 Agents and methods for diagnosing stress |
| 03/28/2007 | EP1766011A1 Polypeptide ligands containing linkers |
| 03/28/2007 | EP1766008A1 Phage screening assay |
| 03/28/2007 | EP1765997A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 03/28/2007 | EP1765994A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof |
| 03/28/2007 | EP1765993A2 Truncated st6galnaci polypeptides and nucleic acids |
| 03/28/2007 | EP1765991A1 Acetyl coa carboxylase splice variant and uses thereof |
| 03/28/2007 | EP1765990A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 03/28/2007 | EP1765845A1 Stable cyanine dye phosphoramidites |
| 03/28/2007 | EP1765416A2 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 03/28/2007 | EP1765415A2 Oligomeric compounds that facilitate risc loading |
| 03/28/2007 | EP1765398A2 Human antibodies interacting with hiv gp41 |
| 03/28/2007 | EP1765387A2 NEEDLE-FREE ADMINISTRATION OF FeLV VACCINES |
| 03/28/2007 | EP1765386A2 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 03/28/2007 | EP1765316A2 Methods and compositions for modulating bax-ku70-mediated apoptosis |
| 03/28/2007 | EP1765148A1 Compound metal analyte sensor |
| 03/28/2007 | EP1765061A2 Citrus sudden death |
| 03/28/2007 | EP1765056A1 Markers for salinity tolerance in wheat plants and the use thereof in breeding programs |
| 03/28/2007 | EP1718743A4 Anti-freeze protein enhanced nucleic acid amplification |
| 03/28/2007 | EP1687445A4 Polymeric nucleic acid hybridization probes |
| 03/28/2007 | EP1685149A4 Primers, methods and kits for detecting killer-cell immunoglobulin-like receptor alleles |
| 03/28/2007 | EP1639126A4 Regulome arrays |
| 03/28/2007 | EP1600510B1 DNA sequences having anti-repressor activity |
| 03/28/2007 | EP1581794A4 Methods of diagnosing and treating cancer |
| 03/28/2007 | EP1546345B1 Genome partitioning |
| 03/28/2007 | EP1453978B1 Analysis and detection of multiple target sequences using circular probes |
| 03/28/2007 | EP1453532A4 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 03/28/2007 | EP1366409A4 Light scatteringdetermination of treatment potencies |
| 03/28/2007 | EP1082416B1 Poly(adp-ribose)polymerase gene |
| 03/28/2007 | CN2883382Y Multiple polymeric enzyme chain type reaction tube |
| 03/28/2007 | CN1938589A Method and apparatus for implementing threshold based correction functions for biosensors |
| 03/28/2007 | CN1938584A Amino acid biosensor, fischer ratio biosensor and health information management system |
| 03/28/2007 | CN1938432A Pdk4 as marker for ppardelta modulation |
| 03/28/2007 | CN1938431A Method of diagnosis of a predisposition to develop thrombotic disease and its uses |
| 03/28/2007 | CN1938430A Methods and devices for using raman-active probe constructs to assay biological samples |
| 03/28/2007 | CN1938424A Sequence capable of accelerating gene expression at moderately low temperature |
| 03/28/2007 | CN1938329A Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules |
| 03/28/2007 | CN1938328A Nucleotide derivative and DNA microarray |
| 03/28/2007 | CN1936584A Fabp4 as marker for a toxic effect |
| 03/28/2007 | CN1936567A Technology for appraising acipenser schrencki and Acipenser datryanus |
| 03/28/2007 | CN1936550A Reagent box for detecting prawn infectious subcutaneous and hemopoietic tissue necrosis virus and method thereof |
| 03/28/2007 | CN1936549A Reagent box for detecting prawn leucoplakia syndrome virus using isothermal branch augmentation and method therefor |
| 03/28/2007 | CN1936023A Diagnostic and monitoring methods for bone loss |
| 03/28/2007 | CN1936022A Brassica campestris ssp. Chinensis cytoplasmic male sterile gene molecular marking method |
| 03/28/2007 | CN1936021A Brassica campestris ssp. Chinensis male sterile molecular marker-assisted selection method |
| 03/28/2007 | CN1936020A Method of detection of nucleic acids with a specific sequence composition |
| 03/28/2007 | CN1936019A Probe coding method for multiplex real-time nucleic acid amplification detection |
| 03/28/2007 | CN1936018A Use of IS256 gene for preparing molecular marker for: dentifying atphogenic bacterium property |
| 03/28/2007 | CN1936017A Glucagon-like peptide-1 receptor gene pleiomorphism and Type2 diabetes correlation |
| 03/28/2007 | CN1936016A Method for verifying exogenous gene amplicon for transgenic plant and product detection |
| 03/28/2007 | CN1936015A Method for determining natto kinase standard activity value |
| 03/28/2007 | CN1936006A Gene of encoding cell wall mannoprotein and use thereof |
| 03/28/2007 | CN1307421C Method and compositions for overcoming resistance to biologic and chemotherapy |
| 03/28/2007 | CN1307308C Nucleotide specific for Escherichia coli 085-type O-antigen |
| 03/28/2007 | CN1307307C Nucleotide specific for Shigella bogdii B14-type O-antigen |
| 03/28/2007 | CN1307306C Nucleotide specific for Escherichia coli 011-type O-antigen |
| 03/28/2007 | CN1307305C Nucleotide sequence specific for O-antigen of E.coli 076 type |
| 03/28/2007 | CN1307304C Primer sequence for identifying cucumber ampho disease and its identification method |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/28/2007 | CA2621970A1 Method for regenerating hydrophilic and osteophilic surface of an implant |
| 03/27/2007 | US7197400 System and computer software products for comparative gene expression analysis |
| 03/27/2007 | US7197169 Method for detecting a response of each probe zone on a test strip |
| 03/27/2007 | US7196364 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 03/27/2007 | US7196183 Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| 03/27/2007 | US7196182 An isolated nucleic acid molecule comprising DNA encoding a polypeptide, and a hybride DNA; programmed cell death, cytokine processing and receptor signal transduction |
| 03/27/2007 | US7196181 made in non-thyroidal eukaryotic cells; for diagnosis and treatment of immune disorders such as Hashimoto's thyroiditis |
| 03/27/2007 | US7196171 Alstrom syndrome is a homogeneous autosomal recessive disorder characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficiency; isolated polypeptide |